Antibiotic use after a typhoid conjugate vaccine: factors beyond vaccination in low-income countries

  18 September 2023

In conclusion, although vaccines have shown potential in reducing antimicrobial resistance, the study on Typbar-TCV in Harare did not find evidence of an effect on antibiotic prescribing. Factors such as unchanged clinical management, insufficient routine immunisation, and limited campaign scope could have contributed to this outcome. Addressing these challenges, such as diagnostics, socioeconomic support, and improved work environments are crucial for effective case management and optimal antibiotic use in low-income countries. Comprehensive approaches are needed to achieve lasting effects on antimicrobial resistance and patient care.

Further reading: The Lancet Global Health
Author(s): Tapfumanei Mashe, Mateusz Hasso-Agopsowicz, Blessmore V Chaibva
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed